Health Plans Can’t Dodge Paying For Expensive New Cancer Treatments, Says Michigan’s Top Insurance Regulator
By ROBIN FIELDS & MAYA MILLER
ProPublica/Co-published with The Capitol Forum
In a victory for many cancer patients in Michigan, the state’s top insurance regulator told health plans last month that they cannot deny coverage for clinically proven cancer treatments, and she made it clear for the first time that this includes cutting-edge genetic and biologic therapies.
The move follows weeks of questions from ProPublica and pressure from state lawmakers after the news organization reported in November that an insurer there refused to pay for the only treatment that could save the life of Forrest VanPatten, a 50-year-old father of two, even though a state law requires insurers to pay for proven cancer drugs.
Internal [Read More]